US Stem Cell Inc (USRM)

[a1tellem]

The article in the LA times is actually pub’d by a writer that’s been very critical on USRM so to say this is a paid news piece Is hilarious. LA TIMES.

And I believe whats being appealed is Ungaro’s interpretation of the law. Which the CA judge disagrees with and went another way. If the CA judge sees it another way, especially with new interpretation of the FDA’s reach, there’s definitely a possibility that another judge or judges could see it the same way.